-
As of late September 2025, new Alzheimer’s drugs like lecanemab and donanemab show promise in slowing disease progression but require early diagnosis and carry risks. The UK’s NHS and Australia face challenges in access and funding, while the UAE highlights the need for improved awareness and infrastructure. Meanwhile, the UK’s rollout of weight-loss drug Mounjaro is underfunded, limiting patient access amid rising demand and GP shortages.
-
Recent studies show Europe’s summer heatwaves caused over 24,000 deaths in 2024, with 68% linked to climate change. Elderly populations are most affected, and wildfires intensified by rising temperatures have worsened health impacts. Experts warn urgent action is needed to adapt infrastructure and reduce risks.
-
As of late November 2025, the US, UK, Canada, and Japan face an early, severe flu season driven by the H3N2 subclade K variant, which has mutated beyond current vaccine strains. Hospital admissions and flu cases, especially among children and vulnerable groups, are rising. Concurrently, norovirus infections are doubling nationwide, with health officials urging hygiene and vaccination to mitigate risks.
-
NHS Tayside destroyed around 40 patient logbooks linked to disgraced neurosurgeon Sam Eljamel despite a 'do not destroy' order. The Scottish inquiry is investigating whether the destruction was gross negligence or malice, amid systemic failures and patient harm. The case highlights accountability issues within NHS Scotland.